NASDAQ: AYTU
Aytu Biopharma Inc Stock Ownership - Who owns Aytu Biopharma?

Insider buying vs selling

Have Aytu Biopharma Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Jarrett DisbrowChief Business Officer2025-06-0916,666$1.50
$25.00kBuy
Joshua R. DisbrowChief Executive Officer2025-06-0966,666$1.50
$100.00kBuy
Joshua R. DisbrowChief Executive Officer2025-02-2815,000$1.30
$19.50kBuy

1 of 1

AYTU insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when AYTU insiders and whales buy or sell their stock.

AYTU Shareholders

What type of owners hold Aytu Biopharma Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Armistice Capital LLC179.55%11,078,956$24.48MInsider
Cerecor Inc157.42%9,713,068$21.47MInsider
James B. Wiegand37.93%2,340,659$5.17MInsider
Ampio Pharmaceuticals Inc19.88%1,226,407$2.71MInsider
Christopher Brooke18.92%1,167,147$2.58MInsider
Nantahala Capital Management LLC17.61%1,086,812$2.40MInstitution
Nantahala Capital Management LLC17.61%1,086,812$2.40MInsider
Carl Dockery14.54%897,425$1.98MInsider
Stonepine Capital Management LLC13.17%812,676$1.80MInstitution
Awm Investment Company Inc10.05%619,874$1.37MInstitution

1 of 3

AYTU vs Pharmaceutical Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
AYTU10.39%89.61%Net BuyingNet Buying
TXMD3.56%96.44%Net Buying
FLGC5.72%94.28%Net Buying
GELS1.12%0.00%
IXHL3.47%15.45%

Aytu Biopharma Stock Ownership FAQ

Who owns Aytu Biopharma?

Aytu Biopharma (NASDAQ: AYTU) is owned by 55.37% institutional shareholders, 477.27% Aytu Biopharma insiders, and 0.00% retail investors. Armistice Capital LLC is the largest individual Aytu Biopharma shareholder, owning 11.08M shares representing 179.55% of the company. Armistice Capital LLC's Aytu Biopharma shares are currently valued at $24.48M.

If you're new to stock investing, here's how to buy Aytu Biopharma stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.